Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Poultry Vaccines Market

Poultry Vaccines Market Size

  • Report ID: GMI10613
  • Published Date: Aug 2024
  • Report Format: PDF

Poultry Vaccines Market Size

Poultry Vaccines Market size was valued at USD 2.3 billion in 2023 and is poised to witness significant growth at 7.1% CAGR between 2024 and 2032. This expansion is attributed to the rising demand for poultry products, including meat and eggs, due to population growth and increasing protein consumption globally. The shift towards protein-rich diets, especially in emerging economies, has led to greater investment in poultry farming, thereby driving the demand for effective disease prevention measures, including animal vaccines.

 

The frequent outbreaks of infectious diseases in poultry, such as avian influenza and Newcastle disease, have underscored the need for robust vaccination programs. These diseases can cause significant economic losses to the poultry industry, making prevention through vaccination a critical priority. Additionally, increased awareness and education among poultry farmers about the benefits of vaccination and biosecurity measures, supported by government and international initiatives, have further encouraged the adoption of poultry vaccines. The combined impact of these factors continues to drive the expansion and diversification of the poultry vaccines market.

 

Poultry vaccines are biological preparations that stimulate an immune response in birds, such as chickens, turkeys, and ducks, to protect them against infectious diseases. These vaccines can contain live or inactivated forms of pathogens and are administered to prevent diseases like Newcastle disease, avian influenza, and Marek's disease. The use of poultry vaccines is essential in poultry farming to maintain flock health, reduce economic losses, and ensure food safety by preventing the spread of infectious agents.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Poultry vaccines market was valued at USD 2.3 billion in 2023 and is poised to witness significant growth at 7.1% CAGR during 2024-2032 attributed to the rising demand for poultry products, including meat and eggs, due to population growth.

The attenuated live vaccines segment in the market is anticipated to grow at 6.9% CAGR through 2032 due to its ability to induce a strong and long-lasting immune response.

North America poultry vaccines market is expected to grow at 7% CAGR to reach USD 1.7 billion by 2032 owing to the sophisticated vaccination programs and biosecurity measures.

Biovac, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, and Merck & Co., Inc. among others.

Poultry Vaccines Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 343
  • Countries covered: 22
  • Pages: 195
 Download Free Sample